BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 15965645)

  • 1. Dendritic cells pulsed with gp96-peptide complexes derived from human hepatocellular carcinoma (HCC) induce specific cytotoxic T lymphocytes.
    Wang XH; Qin Y; Hu MH; Xie Y
    Cancer Immunol Immunother; 2005 Oct; 54(10):971-80. PubMed ID: 15965645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastric cancer-derived heat shock protein-gp96 peptide complex enhances dendritic cell activation.
    Lu WW; Zhang H; Li YM; Ji F
    World J Gastroenterol; 2017 Jun; 23(24):4390-4398. PubMed ID: 28706421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The heat shock protein gp96: a receptor-targeted cross-priming carrier and activator of dendritic cells.
    Singh-Jasuja H; Hilf N; Scherer HU; Arnold-Schild D; Rammensee HG; Toes RE; Schild H
    Cell Stress Chaperones; 2000 Nov; 5(5):462-70. PubMed ID: 11189453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanoma-reactive class I-restricted cytotoxic T cell clones are stimulated by dendritic cells loaded with synthetic peptides, but fail to respond to dendritic cells pulsed with melanoma-derived heat shock proteins in vitro.
    Fleischer K; Schmidt B; Kastenmüller W; Busch DH; Drexler I; Sutter G; Heike M; Peschel C; Bernhard H
    J Immunol; 2004 Jan; 172(1):162-9. PubMed ID: 14688322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen presentation and immune regulatory capacity of immature and mature-enriched antigen presenting (dendritic) cells derived from human bone marrow.
    Jin Y; Fuller L; Ciancio G; Burke GW; Tzakis AG; Ricordi C; Miller J; Esquenzai V
    Hum Immunol; 2004 Feb; 65(2):93-103. PubMed ID: 14969764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cells pulsed with hsp70-peptide complexes derived from human hepatocellular carcinoma induce specific anti-tumor immune responses.
    Wang XH; Qin Y; Hu MH; Xie Y
    World J Gastroenterol; 2005 Sep; 11(36):5614-20. PubMed ID: 16237753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen-loaded dendritic cells triggers a specific cytotoxic T lymphocytes immune response against hepatocellular carcinoma: in vitro study.
    El-Ashmawy NE; El-Zamarany EA; Khedr EG; El-Bahrawy HA; El-Feky OA
    Clin Transl Oncol; 2019 May; 21(5):636-645. PubMed ID: 30368725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendritic cells cultured in anti-CD40 antibody-immobilized plates elicit a highly efficient peptide-specific T-cell response.
    Osada T; Nagawa H; Takahashi T; Tsuno NH; Kitayama J; Shibata Y
    J Immunother; 2002; 25(2):176-84. PubMed ID: 12074047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Maturation regulation of dendritic cells pulsed with hepatocellular carcinoma cell soluble antigens].
    Guo JW; Qin LW; Cai MY; Yu L; Lu TD; Zhang J; Zhang YX; Dong JZ; Deng ZY
    Zhonghua Gan Zang Bing Za Zhi; 2003 Mar; 11(3):135-8. PubMed ID: 12681056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lactobacilli secreting a tumor antigen and IL15 activates neutrophils and dendritic cells and generates cytotoxic T lymphocytes against cancer cells.
    Kandasamy M; Bay BH; Lee YK; Mahendran R
    Cell Immunol; 2011; 271(1):89-96. PubMed ID: 21723537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy based on dendritic cells pulsed with CTPFoxM1 fusion protein protects against the development of hepatocellular carcinoma.
    Su H; Li B; Zheng L; Wang H; Zhang L
    Oncotarget; 2016 Jul; 7(30):48401-48411. PubMed ID: 27351282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro generation of cytotoxic and regulatory T cells by fusions of human dendritic cells and hepatocellular carcinoma cells.
    Koido S; Homma S; Hara E; Mitsunaga M; Namiki Y; Takahara A; Nagasaki E; Komita H; Sagawa Y; Ohkusa T; Fujise K; Gong J; Tajiri H
    J Transl Med; 2008 Sep; 6():51. PubMed ID: 18793383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting heat shock proteins for immunotherapy in multiple myeloma: generation of myeloma-specific CTLs using dendritic cells pulsed with tumor-derived gp96.
    Qian J; Wang S; Yang J; Xie J; Lin P; Freeman ME; Yi Q
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8808-15. PubMed ID: 16361569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-derived heat shock protein 70-pulsed dendritic cells elicit tumor-specific cytotoxic T lymphocytes (CTLs) and tumor immunity.
    Ueda G; Tamura Y; Hirai I; Kamiguchi K; Ichimiya S; Torigoe T; Hiratsuka H; Sunakawa H; Sato N
    Cancer Sci; 2004 Mar; 95(3):248-53. PubMed ID: 15016325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and cellular requirements for enhanced antigen cross-presentation to CD8 cytotoxic T lymphocytes.
    Oizumi S; Strbo N; Pahwa S; Deyev V; Podack ER
    J Immunol; 2007 Aug; 179(4):2310-7. PubMed ID: 17675492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD11c+ blood dendritic cells induce antigen-specific cytotoxic T lymphocytes with similar efficiency compared to monocyte-derived dendritic cells despite higher levels of MHC class I expression.
    Radford KJ; Turtle CJ; Kassianos AJ; Hart DN
    J Immunother; 2006; 29(6):596-605. PubMed ID: 17063122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines.
    Schnurr M; Galambos P; Scholz C; Then F; Dauer M; Endres S; Eigler A
    Cancer Res; 2001 Sep; 61(17):6445-50. PubMed ID: 11522639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The infection of human dendritic cells with recombinant avipox vectors expressing a costimulatory molecule transgene (CD80) to enhance the activation of antigen-specific cytolytic T cells.
    Tsang KY; Zhu M; Even J; Gulley J; Arlen P; Schlom J
    Cancer Res; 2001 Oct; 61(20):7568-76. PubMed ID: 11606396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cells pulsed with placental gp96 promote tumor-reactive immune responses.
    Zheng H; Liu L; Zhang H; Kan F; Wang S; Li Y; Tian H; Meng S
    PLoS One; 2019; 14(1):e0211490. PubMed ID: 30703157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presentation of tumor antigens by dendritic cells genetically modified with viral and nonviral vectors.
    Lotem M; Zhao Y; Riley J; Hwu P; Morgan RA; Rosenberg SA; Parkhurst MR
    J Immunother; 2006; 29(6):616-27. PubMed ID: 17063124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.